| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Are there alternatives to mortality as an endpoint in clinical trials of atrial fibrillation?
|
George Wyse, D
|
|
2004
|
1 |
2S |
p. 41-44
4 p.
|
artikel
|
| 2 |
Atrial fibrillation endpoints: hospitalization
|
Ruskin, Jeremy N
|
|
2004
|
1 |
2S |
p. 31-35
5 p.
|
artikel
|
| 3 |
Diagnostic information in implantable devices that pertain to endpoints in atrial fibrillation studies
|
Mehra, Rahul
|
|
2004
|
1 |
2S |
p. 64-69
6 p.
|
artikel
|
| 4 |
Editorial board
|
|
|
2004
|
1 |
2S |
p. 70-
1 p.
|
artikel
|
| 5 |
Mortality as an endpoint in atrial fibrillation 1 1 Processed by a guest editor.
|
Beyerbach, Daniel M
|
|
2004
|
1 |
2S |
p. 8-19
12 p.
|
artikel
|
| 6 |
Overview of endpoints in atrial fibrillation studies
|
George Wyse, D
|
|
2004
|
1 |
2S |
p. 3-7
5 p.
|
artikel
|
| 7 |
Overview of symposium: outcomes in AF trials
|
Mehra, Rahul
|
|
2004
|
1 |
2S |
p. 1-2
2 p.
|
artikel
|
| 8 |
Quality of life as an endpoint for atrial fibrillation research: pitfalls and practice
|
Newman, David
|
|
2004
|
1 |
2S |
p. 20-26
7 p.
|
artikel
|
| 9 |
Rhythm control in atrial fibrillation: endpoints for device-based trials
|
Gillis, Anne M
|
|
2004
|
1 |
2S |
p. 52-57
6 p.
|
artikel
|
| 10 |
Sample size estimates for atrial fibrillation endpoints
|
Warman, Eduardo N
|
|
2004
|
1 |
2S |
p. 58-63
6 p.
|
artikel
|
| 11 |
Stroke and bleeding as an endpoint in atrial fibrillation studies
|
Trang Dinh, N.H
|
|
2004
|
1 |
2S |
p. 27-30
4 p.
|
artikel
|
| 12 |
Symptomatic arrhythmia recurrence as an outcome in clinical trials of antiarrhythmic drug therapy
|
Pritchett, Edward L.C
|
|
2004
|
1 |
2S |
p. 36-40
5 p.
|
artikel
|
| 13 |
Ventricular rate control as an endpoint for treatment of atrial fibrillation
|
Wood, Mark A
|
|
2004
|
1 |
2S |
p. 45-51
7 p.
|
artikel
|
Tijdschrift beschrijving